ISSN 1671-5411 CN 11-5329/R
Volume 19 Issue 1
Jan.  2022
Turn off MathJax
Article Contents
Please cite this article as: WANG JJ, ZHUANG ZH, YU CQ, WANG WY, WANG WX, ZHANG K, MENG XB, GAO J, TIAN J, ZHENG JL, YANG J, HUANG T, SHAO CL, TANG YD. Assessment of causal direction between thyroid function and cardiometabolic health: a Mendelian randomization study. J Geriatr Cardiol 2022; 19(1): 61−70. DOI: 10.11909/j.issn.1671-5411.2022.01.004
Citation: Please cite this article as: WANG JJ, ZHUANG ZH, YU CQ, WANG WY, WANG WX, ZHANG K, MENG XB, GAO J, TIAN J, ZHENG JL, YANG J, HUANG T, SHAO CL, TANG YD. Assessment of causal direction between thyroid function and cardiometabolic health: a Mendelian randomization study. J Geriatr Cardiol 2022; 19(1): 61−70. DOI: 10.11909/j.issn.1671-5411.2022.01.004

Assessment of causal direction between thyroid function and cardiometabolic health: a Mendelian randomization study

doi: 10.11909/j.issn.1671-5411.2022.01.004
More Information
  •  BACKGROUND  Growing evidence have demonstrated that thyroid hormones have been involved in the processes of cardiovascular metabolism. However, the causal relationship of thyroid function and cardiometabolic health remains partly unknown. METHODS  The Mendelian randomization (MR) was used to test genetic, potentially causal relationships between instrumental variables and cardiometabolic traits. Genetic variants of free thyroxine (FT4) and thyrotropin (TSH) levels within the reference range were used as instrumental variables. Data for genetic associations with cardiometabolic diseases were acquired from the genome-wide association studies of the FinnGen, CARDIoGRAM and CARDIoGRAMplusC4D, CHARGE, and MEGASTROKE. This study was conducted using summary statistic data from large, previously described cohorts. Association between thyroid function and essential hypertension (EHTN), secondary hypertension (SHTN), hyperlipidemia (HPL), type 2 diabetes mellitus (T2DM), ischemic heart disease (IHD), myocardial infarction (MI), heart failure (HF), pulmonary heart disease (PHD), stroke, and non-rheumatic valve disease (NRVD) were examined. RESULTS  Genetically predicted FT4 levels were associated with SHTN (odds ratio = 0.48; 95% CI = 0.04−0.82, P = 0.027), HPL (odds ratio = 0.67; 95% CI = 0.18−0.88, P = 0.023), T2DM (odds ratio = 0.80; 95% CI = 0.42−0.86, P = 0.005), IHD (odds ratio = 0.85; 95% CI = 0.49−0.98, P = 0.039), NRVD (odds ratio = 0.75; 95% CI = 0.27−0.97, P = 0.039). Additionally, genetically predicted TSH levels were associated with HF (odds ratio = 0.82; 95% CI = 0.68−0.99, P = 0.042), PHD (odds ratio = 0.75; 95% CI = 0.32−0.82, P = 0.006), stroke (odds ratio = 0.95; 95% CI = 0.81−0.97, P = 0.007). However, genetically predicted thyroid function traits were not associated with EHTN and MI. CONCLUSIONS Our study suggests FT4 and TSH are associated with cardiometabolic diseases, underscoring the importance of the pituitary-thyroid-cardiac axis in cardiometabolic health susceptibility.
  • loading
  • [1]
    Powell KL, Stephens SR, Stephens AS. Cardiovascular risk factor mediation of the effects of education and Genetic Risk Score on cardiovascular disease: a prospective observational cohort study of the Framingham Heart Study. BMJ Open 2021; 11: e045210.
    Eckel RH, Blaha MJ. Cardiometabolic Medicine: A call for a new subspeciality training track in internal medicine. Am J Med 2019; 132: 788−790. doi: 10.1016/j.amjmed.2019.02.027
    Bianco AC, Salvatore D, Gereben B, et al. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 2002; 23: 38−89. doi: 10.1210/edrv.23.1.0455
    Grais IM, Sowers JR. Thyroid and the heart. Am J Med 2014; 127: 691−698. doi: 10.1016/j.amjmed.2014.03.009
    Selmer C, Olesen JB, Hansen ML, et al. Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: a large population study. J Clin Endocrinol Metab 2014; 99: 2372−2382. doi: 10.1210/jc.2013-4184
    Chaker L, Baumgartner C, den Elzen WP, et al. Subclinical hypothyroidism and the risk of stroke events and fatal stroke: an individual participant data analysis. J Clin Endocrinol Metab 2015; 100: 2181−2191. doi: 10.1210/jc.2015-1438
    Collet TH, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 2012; 172: 799−809.
    Dekkers OM, Horvath-Puho E, Cannegieter SC, et al. Acute cardiovascular events and all-cause mortality in patients with hyperthyroidism: a population-based cohort study. Eur J Endocrinol 2017; 176: 1−9. doi: 10.1530/EJE-16-0576
    Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 2010; 304: 1365−1374. doi: 10.1001/jama.2010.1361
    Bano A, Chaker L, Mattace-Raso FU, et al. Thyroid function and the risk of atherosclerotic cardiovascular morbidity and mortality: the Rotterdam study. Circ Res 2017; 121: 1392−1400. doi: 10.1161/CIRCRESAHA.117.311603
    Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489−499. doi: 10.1210/jcem.87.2.8182
    Lawlor DA, Harbord RM, Sterne JA, et al. Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 2008; 27: 1133−1163. doi: 10.1002/sim.3034
    Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 2015; 44: 512−525. doi: 10.1093/ije/dyv080
    Ellervik C, Roselli C, Christophersen IE, et al. Assessment of the relationship between genetic determinants of thyroid function and atrial fibrillation: A Mendelian Randomization Study. JAMA Cardiol 2019; 4: 144−152. doi: 10.1001/jamacardio.2018.4635
    Teumer A, Chaker L, Groeneweg S, et al. Genome-wide analyses identify a role for SLC17A4 and AADAT in thyroid hormone regulation. Nat Commun. 2018; 9: 4455.
    Schultheiss UT, Teumer A, Medici M, et al. A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations. J Clin Endocrinol Metab 2015; 100: E799−E807. doi: 10.1210/jc.2014-4352
    The FinnGen consortium. FinnGen documentation of R3 release, 2020. (accessed on July 28, 2020).
    Nikpay M, Goel A, Won HH, et al. A comprehensive 1, 000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nat Genet 2015; 47: 1121−1130. doi: 10.1038/ng.3396
    Smith NL, Felix JF, Morrison AC, et al. Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Circ Cardiovasc Genet 2010; 3: 256−266. doi: 10.1161/CIRCGENETICS.109.895763
    Malik R, Chauhan G, Traylor M, et al. Multiancestry genome-wide association study of 520, 000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet 2018; 50: 524−537. doi: 10.1038/s41588-018-0058-3
    Loehr LR, Rosamond WD, Chang PP, et al. Heart failure incidence and survival (from the Atherosclerosis Risk in Communities study). Am J Cardiol 2008; 101: 1016−1022. doi: 10.1016/j.amjcard.2007.11.061
    White AD, Folsom AR, Chambless LE, et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) Study: methods and initial two years' experience. J Clin Epidemiol 1996; 49: 223−233. doi: 10.1016/0895-4356(95)00041-0
    Ives DG, Fitzpatrick AL, Bild DE, et al. Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol 1995; 5: 278−285.
    McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med 1971; 285: 1441−1446. doi: 10.1056/NEJM197112232852601
    Bleumink GS, Knetsch AM, Sturkenboom MC, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. Eur Heart J 2004; 25: 1614−1619. doi: 10.1016/j.ehj.2004.06.038
    Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001; 22: 1527−1560. doi: 10.1053/euhj.2001.2783
    Genomes Project C, Abecasis GR, Auton A, et al. An integrated map of genetic variation from 1, 092 human genomes. Nature 2012; 491: 56−65. doi: 10.1038/nature11632
    Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 2013; 37: 658−665. doi: 10.1002/gepi.21758
    Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol 2017; 46: 1985−1998. doi: 10.1093/ije/dyx102
    Yavorska OO, Burgess S. Mendelian randomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol 2017; 46: 1734−39. doi: 10.1093/ije/dyx034
    Bowden J, Davey Smith G, Haycock PC, et al. Consistent Estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 2016; 40: 304−314. doi: 10.1002/gepi.21965
    Kus A, Marouli E, Del Greco MF, et al. Variation in normal range thyroid function affects serum cholesterol levels, blood pressure, and type 2 diabetes risk: a Mendelian randomization study. Thyroid 2021; 31: 721−731. doi: 10.1089/thy.2020.0393
    Bos MM, Smit RAJ, Trompet S, et al. Thyroid Signaling, Insulin Resistance, and 2 Diabetes Mellitus: A Mendelian Randomization Study. J Clin Endocrinol Metab 2017; 102: 1960−1970. doi: 10.1210/jc.2016-2816
    Kong X, Wang J, Gao G, et al. Association between free thyroxine levels and diabetic retinopathy in euthyroid patients with type 2 diabetes mellitus. Endocr Res 2020; 45: 111−118. doi: 10.1080/07435800.2019.1690504
    Beukhof CM, Massolt ET, Visser TJ, et al. Effects of thyrotropin on peripheral thyroid hormone metabolism and serum lipids. Thyroid 2018; 28: 168−174. doi: 10.1089/thy.2017.0330
    Michalopoulou G, Alevizaki M, Piperingos G, et al. High serum cholesterol levels in persons with ‘high-normal’ TSH levels: should one extend the definition of subclinical hypothyroidism? Eur J Endocrinol 1998; 138: 141−145.
    Martin SS, Daya N, Lutsey PL, et al. Thyroid function, cardiovascular risk factors, and incident atherosclerotic cardiovascular disease: the Atherosclerosis Risk in Communities (ARIC) Study. J Clin Endocrinol Metab 2017; 102: 3306−3315. doi: 10.1210/jc.2017-00986
    He W, Li S, Wang B, et al. Dose-response relationship between thyroid stimulating hormone and hypertension risk in euthyroid individuals. J Hypertens 2019; 37: 144−153. doi: 10.1097/HJH.0000000000001826
    Larsson SC, Allara E, Mason AM, et al. Thyroid function and dysfunction in relation to 16 cardiovascular diseases. Circ Genom Precis Med 2019; 12: e002468.
    Iervasi G, Molinaro S, Landi P, et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med 2007; 167: 1526−1532. doi: 10.1001/archinte.167.14.1526
    Takamura N, Akilzhanova A, Hayashida N, et al. Thyroid function is associated with carotid intima-media thickness in euthyroid subjects. Atherosclerosis 2009; 204: e77−e81. doi: 10.1016/j.atherosclerosis.2008.09.022
    Boekholdt SM, Titan SM, Wiersinga WM, et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf) 2010; 72: 404−410. doi: 10.1111/j.1365-2265.2009.03640.x
    Zhao JV, Schooling CM. Thyroid function and ischemic heart disease: a Mendelian randomization study. Sci Rep 2017; 7: 8515. doi: 10.1038/s41598-017-07592-z
    Park HJ, Kim J, Han EJ, et al. Association of low baseline free thyroxin levels with progression of coronary artery calcification over 4 years in euthyroid subjects: the Kangbuk Samsung Health Study. Clin Endocrinol (Oxf) 2016; 84: 889−895. doi: 10.1111/cen.12946
    Fukuyama K, Ichiki T, Imayama I, et al. Thyroid hormone inhibits vascular remodeling through suppression of cAMP response element binding protein activity. Arterioscler Thromb Vasc Biol 2006; 26: 2049−2055. doi: 10.1161/01.ATV.0000233358.87583.01
    Xiang GD, He YS, Zhao LS, et al. Impairment of endothelium-dependent arterial dilation in Hashimoto’s thyroiditis patients with euthyroidism. Clin Endocrinol (Oxf) 2006; 64: 698−702. doi: 10.1111/j.1365-2265.2006.02531.x
    Lee JJ, Pedley A, Marqusee E, et al. Thyroid function and cardiovascular disease risk factors in euthyroid adults: a cross-sectional and longitudinal study. Clin Endocrinol (Oxf) 2016; 85: 932−941. doi: 10.1111/cen.13124
    Bozkurt B, Colvin M, Cook J, et al. Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the american heart association. Circulation 2016; 134: e579−e646.
    Seghieri G, Bardini G, Fascetti S, et al. Stroke is related to lower serum thyrotropin levels in patients with diabetes mellitus. Diabetes Res Clin Pract 2003; 62: 203−209. doi: 10.1016/j.diabres.2003.08.001
    Scicchitano P, Dentamaro I, Tunzi F, et al. Pulmonary hypertension in thyroid diseases. Endocrine 2016; 54: 578−587. doi: 10.1007/s12020-016-0923-8
    Channick BJ, Adlin EV, Marks AD, et al. Hyperthyroidism and mitral-valve prolapse. N Engl J Med 1981; 305: 497−500. doi: 10.1056/NEJM198108273050906
    Zullo MA, Devereux RB, Kramer-Fox R, et al. Mitral valve prolapse and hyperthyroidism: effect of patient selection. Am Heart J 1985; 110: 977−980. doi: 10.1016/0002-8703(85)90195-4
  • JGC-202105-038Supplementary.pdf
  • 加载中


    通讯作者: 陈斌,
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(3)

    Article Metrics

    Article views (444) PDF downloads(52) Cited by()
    Proportional views


    DownLoad:  Full-Size Img  PowerPoint